TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

EBITDA Summary of TFBS Bioscience Inc.

  • TFBS Bioscience Inc.'s latest annual EBITDA in 2023 was 64.15 Million TWD , down -13.28% from previous year.
  • TFBS Bioscience Inc.'s latest quarterly EBITDA in 2023 FY was N/A , down -13.28% from previous quarter.
  • TFBS Bioscience Inc. reported an annual EBITDA of 68.33 Million TWD in 2022, up 129.35% from previous year.
  • TFBS Bioscience Inc. reported an annual EBITDA of 32.75 Million TWD in 2021, up 26.45% from previous year.
  • TFBS Bioscience Inc. reported a quarterly EBITDA of N/A for 2022 FY, up 129.35% from previous quarter.
  • TFBS Bioscience Inc. reported a quarterly EBITDA of N/A for 2021 FY, up 26.45% from previous quarter.

Annual EBITDA Chart of TFBS Bioscience Inc. (2023 - 2020)

Historical Annual EBITDA of TFBS Bioscience Inc. (2023 - 2020)

Year EBITDA EBITDA Growth
2023 64.15 Million TWD -13.28%
2022 68.33 Million TWD 129.35%
2021 32.75 Million TWD 26.45%
2020 25.9 Million TWD 0.0%

Peer EBITDA Comparison of TFBS Bioscience Inc.

Name EBITDA EBITDA Difference
BIONET Corp. 147.09 Million TWD 56.387%
DIVA Laboratories, Ltd. 100.31 Million TWD 36.05%
Genetics Generation Advancement Corp. 50.6 Million TWD -26.774%
Welgene Biotech Co.,Ltd. 26.83 Million TWD -139.051%
Puriblood Medical Co., Ltd. -44.01 Million TWD 245.748%